Cardinal Health, Inc. CAH
- Market cap
- $51.6B
- P/E
- 30.3×
Follow CAH
Cardinal Health, Inc. (CAH) EV/EBITDA
As of 25 September 2026, Cardinal Health, Inc. (CAH) trades at a EV/EBITDA of 15.7×. Over the past ten years it has ranged from 0.0× (December 2022) to 241× (September 2022); the current reading is higher than 74% of that period. That is in line with the Medical Distribution industry median of 15.5× and above the Healthcare sector median of 10.4×.
EV/EBITDA, daily
Annual
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2026 | 16.8× | 14.33% |
| FY2025 | 14.7× | 20.30% |
| FY2024 | 12.2× | (30.15%) |
| FY2023 | 17.5× | (90.19%) |
| FY2022 | 179× | 1,049.52% |
| FY2021 | 15.5× | — |
| FY2020 | 0.0× | — |
| FY2019 | 6.5× | (66.95%) |
| FY2018 | 19.5× | 96.52% |
| FY2017 | 9.9× | 7.46% |
Quarterly
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 16.8× | (0.27%) |
| Mar 2026 | 16.9× | 5.35% |
| Dec 2025 | 16.0× | 23.32% |
| Sep 2025 | 13.0× | (11.76%) |
| 42 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| COSM Cosmos Health Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| ACH Accendra Health, Inc. compare | 8.2× |
| HSIC Henry Schein, Inc. compare | 12.0× |
| MCK McKesson Corporation compare | 15.5× |
| CAH Cardinal Health, Inc. | 15.7× |
| COR Cencora, Inc. compare | 16.6× |
| Medical Distribution industry median | 15.5× |
| Healthcare sector median | 10.4× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on CAH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement